Shanghai Medicilon Inc.

SHSE:688202 Stock Report

Market Cap: CN¥9.3b

Shanghai Medicilon Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chun-Lin Chen

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentagen/a
CEO tenure22yrs
CEO ownership11.8%
Management average tenure1yr
Board average tenure1yr

Recent management updates

Recent updates

Shanghai Medicilon Inc.'s (SHSE:688202) 30% Share Price Surge Not Quite Adding Up

Feb 20
Shanghai Medicilon Inc.'s (SHSE:688202) 30% Share Price Surge Not Quite Adding Up

Slammed 26% Shanghai Medicilon Inc. (SHSE:688202) Screens Well Here But There Might Be A Catch

Jan 06
Slammed 26% Shanghai Medicilon Inc. (SHSE:688202) Screens Well Here But There Might Be A Catch

Shanghai Medicilon Inc. (SHSE:688202) Might Not Be As Mispriced As It Looks

Sep 27
Shanghai Medicilon Inc. (SHSE:688202) Might Not Be As Mispriced As It Looks

Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?

Jun 07
Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?

Market Cool On Shanghai Medicilon Inc.'s (SHSE:688202) Revenues Pushing Shares 27% Lower

Apr 25
Market Cool On Shanghai Medicilon Inc.'s (SHSE:688202) Revenues Pushing Shares 27% Lower

CEO

Chun-Lin Chen (63 yo)

22yrs
Tenure
CN¥1,315,000
Compensation

Dr. Chun-Lin Chen, Ph D Co-founded Shanghai Medicilon, Inc. in 2004 and serves as its Chief Executive Officer and Chairman since January 13, 2025. Dr. Chen Co-founded Medicilon-MPI Preclinical Research Sha...

Leadership Team

NamePositionTenureCompensationOwnership
Chun-Lin Chen
Co-Founder22yrsCN¥1.32m11.81%
CN¥ 1.1b
Shuangqing Peng
Chief Scientific Officer8.6yrsCN¥875.80kno data
Jinna Cai
Chief Commercial Officer5yrsCN¥902.40kno data
Binbin Liu
Deputy General Manager1yrCN¥1.02mno data
Jianglin Hu
Joint CEO1yrno datano data
Donghua Zhang
Financial Director1yrno datano data
Fang Hong Chen
Accounting Supervisorno datano datano data
Lilly Xu
Chief Technology Officer1yrno datano data
Jiang Xu
Manager of Human Resources Departmentno datano datano data
Haizhou Zhang
President of Preclinical R&D Unit2yrsno datano data
Qingcong Lin
Deputy GM & Director1yrno datano data
Guo Kai Chen
Deputy GM & Director1yrno datano data
1.0yrs
Average Tenure
57.5yo
Average Age

Experienced Management: 688202's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Chun-Lin Chen
Co-Founder1yrCN¥1.32m11.81%
CN¥ 1.1b
Jinna Cai
Chief Commercial Officerno dataCN¥902.40kno data
Qingcong Lin
Deputy GM & Director1yrno datano data
Guo Kai Chen
Deputy GM & Director1yrno datano data
Weichun Jin
Supervisor9.4yrsno datano data
Dawei Ma
Independent Director4.2yrsCN¥120.00kno data
Weidong Lai
Independent Director4.2yrsCN¥120.00kno data
Yong Hang Chen
Director1yrno datano data
Jian Feng Wang
Independent Director1yrno datano data
Pin Jiang
Chairman of the Board of Supervisors1yrno datano data
Zhu Du
Employee Representative Supervisor1yrno datano data
1.0yrs
Average Tenure
54yo
Average Age

Experienced Board: 688202's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/16 08:34
End of Day Share Price 2026/01/16 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shanghai Medicilon Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan Yuan SunIndustrial Securities Co. Ltd.